Bamlanivimab Terminated Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04656691At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19